{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:12:16Z","timestamp":1793301136859,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["16SDG30410018"],"award-info":[{"award-number":["16SDG30410018"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01 HL142627"],"award-info":[{"award-number":["R01 HL142627"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.yjmcc.2020.03.003","type":"journal-article","created":{"date-parts":[[2020,3,10]],"date-time":"2020-03-10T22:18:07Z","timestamp":1583878687000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice"],"prefix":"10.1016","volume":"141","author":[{"given":"Chengming","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Pretorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Menasche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.yjmcc.2020.03.003_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000558","article-title":"Heart disease and stroke statistics-2018 update: a report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2020.03.003_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.RES.83.1.15","article-title":"Survey of studies examining mammalian cardiomyocyte DNA synthesis","volume":"83","author":"Soonpaa","year":"1998","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.03.003_bb0015","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacc.2017.06.012","article-title":"Overcoming the roadblocks to cardiac cell therapy using tissue engineering","volume":"70","author":"Yanamandala","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"issue":"16","key":"10.1016\/j.yjmcc.2020.03.003_bb0020","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/CIRCULATIONAHA.117.030785","article-title":"Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine","volume":"137","author":"Gao","year":"2018","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.yjmcc.2020.03.003_bb0025","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.5966\/sctm.2015-0044","article-title":"Functional effects of a tissue-engineered cardiac patch from human induced pluripotent stem cell-derived Cardiomyocytes in a rat infarct model","volume":"4","author":"Wendel","year":"2015","journal-title":"Stem Cells Transl. Med."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.03.003_bb0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCRESAHA.112.269894","article-title":"Bioenergetic and functional consequences of cellular therapy: activation of endogenous cardiovascular progenitor cells","volume":"111","author":"Xiong","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2020.03.003_bb0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-4939-2572-8_8","article-title":"Fabrication of a myocardial patch with cells differentiated from human-induced pluripotent stem cells","volume":"1299","author":"Ye","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.03.003_bb0040","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.stem.2014.11.009","article-title":"Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells","volume":"15","author":"Ye","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"30","key":"10.1016\/j.yjmcc.2020.03.003_bb0045","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1093\/eurheartj\/ehv189","article-title":"Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report","volume":"36","author":"Menasche","year":"2015","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.03.003_bb0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","article-title":"Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction","volume":"71","author":"Menasche","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7700","key":"10.1016\/j.yjmcc.2020.03.003_bb0055","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41586-018-0016-3","article-title":"Advanced maturation of human cardiac tissue grown from pluripotent stem cells","volume":"556","author":"Ronaldson-Bouchard","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.yjmcc.2020.03.003_bb0060","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/CIRCRESAHA.113.300216","article-title":"Patching the heart: cardiac repair from within and outside","volume":"113","author":"Ye","year":"2013","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.03.003_bb0065","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/CIRCRESAHA.118.311213","article-title":"Can we engineer a human cardiac patch for therapy?","volume":"123","author":"Zhang","year":"2018","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.yjmcc.2020.03.003_bb0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.yjmcc.2020.03.003_bb0075","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1101\/gad.1306705","article-title":"p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes","volume":"19","author":"Engel","year":"2005","journal-title":"Genes Dev."},{"issue":"42","key":"10.1016\/j.yjmcc.2020.03.003_bb0080","doi-asserted-by":"crossref","first-page":"15546","DOI":"10.1073\/pnas.0607382103","article-title":"FGF1\/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction","volume":"103","author":"Engel","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.03.003_bb0085","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1006\/jmcc.1998.0654","article-title":"Intramyocardial infusion of FGF-1 mimics ischemic preconditioning in pig myocardium","volume":"30","author":"Htun","year":"1998","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2020.03.003_bb0090","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0008-6363(02)00494-7","article-title":"Angiogenesis-independent cardioprotection in FGF-1 transgenic mice","volume":"55","author":"Buehler","year":"2002","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"10.1016\/j.yjmcc.2020.03.003_bb0095","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1172\/JCI36245","article-title":"Deletion of GSK-3beta in mice leads to hypertrophic cardiomyopathy secondary to cardiomyoblast hyperproliferation","volume":"118","author":"Kerkela","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2020.03.003_bb0100","doi-asserted-by":"crossref","first-page":"24637","DOI":"10.1038\/srep24637","article-title":"Induction of human iPSC-derived cardiomyocyte proliferation revealed by combinatorial screening in high density microbioreactor arrays","volume":"6","author":"Titmarsh","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.yjmcc.2020.03.003_bb0105","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCGENETICS.113.000330","article-title":"Identification of chemicals inducing cardiomyocyte proliferation in developmental stage-specific manner with pluripotent stem cells","volume":"6","author":"Uosaki","year":"2013","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"5","key":"10.1016\/j.yjmcc.2020.03.003_bb0110","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jacbts.2018.07.005","article-title":"Discovery of a small molecule to increase Cardiomyocytes and protect the heart after ischemic injury","volume":"3","author":"Hara","year":"2018","journal-title":"JACC Basic Transl. Sci."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.03.003_bb0115","doi-asserted-by":"crossref","first-page":"H278","DOI":"10.1152\/ajpheart.00471.2017","article-title":"VEGF nanoparticles repair the heart after myocardial infarction","volume":"314","author":"Oduk","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2020.03.003_bb0120","first-page":"2667","article-title":"Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model","volume":"6","author":"Binsalamah","year":"2011","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.yjmcc.2020.03.003_bb0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/CIRCULATIONAHA.108.799700","article-title":"Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway","volume":"119","author":"Zhu","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.yjmcc.2020.03.003_bb0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/cvr\/cvu118","article-title":"P53 inhibition exacerbates late-stage anthracycline cardiotoxicity","volume":"103","author":"Zhu","year":"2014","journal-title":"Cardiovasc. Res."},{"issue":"12","key":"10.1016\/j.yjmcc.2020.03.003_bb0135","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1172\/JCI81870","article-title":"Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload","volume":"127","author":"Toischer","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.yjmcc.2020.03.003_bb0140","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1161\/CIRCRESAHA.116.308544","article-title":"Loss of adult cardiac myocyte GSK-3 leads to mitotic catastrophe resulting in fatal dilated cardiomyopathy","volume":"118","author":"Zhou","year":"2016","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.03.003_bb0145","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1161\/CIRCRESAHA.118.311209","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes as models for cardiac channelopathies: a primer for non-electrophysiologists","volume":"123","author":"Garg","year":"2018","journal-title":"Circ. Res."},{"issue":"7625","key":"10.1016\/j.yjmcc.2020.03.003_bb0150","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature19815","article-title":"Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts","volume":"538","author":"Shiba","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.yjmcc.2020.03.003_bb0155","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1161\/CIRCRESAHA.117.311504","article-title":"CCND2 overexpression enhances the regenerative potency of human induced pluripotent stem cell-derived cardiomyocytes: remuscularization of injured ventricle","volume":"122","author":"Zhu","year":"2018","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.yjmcc.2020.03.003_bb0160","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2016015273","article-title":"PLGA nanoparticles and their versatile role in anticancer drug delivery","volume":"33","author":"Khan","year":"2016","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"issue":"12","key":"10.1016\/j.yjmcc.2020.03.003_bb0165","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.117.311920","article-title":"Thyroid and glucocorticoid hormones promote functional T-tubule development in human-induced pluripotent stem cell-derived Cardiomyocytes","volume":"121","author":"Parikh","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2020.03.003_bb0170","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biomaterials.2018.01.002","article-title":"Engineered cardiac tissue patch maintains structural and electrical properties after epicardial implantation","volume":"159","author":"Jackman","year":"2018","journal-title":"Biomaterials"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282820300584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282820300584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T05:59:29Z","timestamp":1762667969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282820300584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":34,"alternative-id":["S0022282820300584"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2020.03.003","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CHIR99021 and fibroblast growth factor 1 enhance the regenerative potency of human cardiac muscle patch after myocardial infarction in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2020.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}